Table 1 Baseline characteristics
N | % | |
|---|---|---|
Total number of patients | 14 | |
Age | ||
Median (Range) | 69.5 (38–88) | |
Gender | ||
Male | 9 | 64 |
Female | 5 | 36 |
Race | ||
White | 14 | 100 |
Performance Status (PS) | ||
0 | 7 | 50 |
1 | 7 | 50 |
Extra-lymphatic sites involved | ||
0 | 8 | 57 |
1 | 1 | 7 |
2 | 3 | 21 |
>2 | 2 | 14 |
Elevated LDH | 6 | 43 |
Bone Marrow Involvement | 1 | 7 |
B symptom | 0 | 0 |
Mediastinal mass | 0 | 0 |
Lymph node or aggregate with a diameter >5 cm | 5 | 36 |
Prior Treatment | ||
Prior Chemotherapy | 14 | 100 |
Prior Immunotherapy | 4 | 29 |
Prior Radiation Therapy | 4 | 29 |
Prior Surgery (with therapeutic intent) | 1 | 7 |
Prior Bone Marrow Transplant* | 3 | 21 |
Other Prior Therapy** | 1 | 7 |